"Propiolactone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disinfectant used in vapor form to sterilize vaccines, grafts, etc. The vapor is very irritating and the liquid form is carcinogenic.
| Descriptor ID |
D011420
|
| MeSH Number(s) |
D02.540.600
|
| Concept/Terms |
Propiolactone- Propiolactone
- beta-Propiolactone
- beta Propiolactone
- Propanolide
|
Below are MeSH descriptors whose meaning is more general than "Propiolactone".
Below are MeSH descriptors whose meaning is more specific than "Propiolactone".
This graph shows the total number of publications written about "Propiolactone" by people in this website by year, and whether "Propiolactone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Propiolactone" by people in Profiles.
-
Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using ß-propiolactone-inactivated, whole virus-based indirect ELISA. J Virol Methods. 2021 01; 287:113996.
-
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET. Structure. 2020 11 03; 28(11):1218-1224.e4.
-
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020 09 08; 324(10):951-960.
-
Propagation, Inactivation, and Safety Testing of SARS-CoV-2. Viruses. 2020 06 06; 12(6).
-
The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease. Vaccine. 2018 06 07; 36(24):3445-3452.
-
Immunogenicity and protective efficacy in mice and hamsters of a ß-propiolactone inactivated whole virus SARS-CoV vaccine. Viral Immunol. 2010 Oct; 23(5):509-19.
-
SARS vaccine protective in mice. Emerg Infect Dis. 2005 Aug; 11(8):1312-4.
-
[Conditions for SARS-CoV cultivation and inactivation]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Jun; 19(2):135-7.
-
Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice. DNA Cell Biol. 2004 Jun; 23(6):391-4.
-
Responses of mice to murine coronavirus immunization. Arch Virol. 1992; 125(1-4):39-52.